country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Cat. No.: HY-169296

Copy Link Print Information

IMPDH2-IN-4

IMPDH2-IN-4 (Compound 2d) is a selective IMPDH2 inhibitor with a K_i,app value of 1.8 μM. IMPDH2-IN-4 exhibits anti-cancer activity against osteosarcoma. IMPDH2-IN-4 can be used in research related to osteosarcoma.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

Formule: C₃₅H₃₄O₆Si
Masse moléculaire:578.73

Stockage:

Please store the product under the recommended conditions in the Certificate of Analysis.

Data Sheet (272 KB)

IMPDH2-IN-4 Chemical Structure

Size

Prix

Stock

Quantité

Amount: USD 0.00

* Veuillez sélectionner la quantité avant d'ajouter des articles.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Activité biologique
- Description
- IC₅₀ & Target
- In Vitro
Chemical Information
Pureté et documentation
Références
Calculators
Help & FAQs
Classifications
Bioz

Activité biologique

Description

IC₅₀ & Target^[1]

IMPDH2

1.8 μM (Ki app)

In Vitro

IMPDH2-IN-4 (0.1-100.0 μM for hFOB; 72 h) potently inhibits the viability of 143B, MNNG/HOS, U2OS and SaOS-2 osteosarcoma cells, with IC₅₀ values ranging from 0.64 to 2.27 μM, while exhibiting low cytotoxicity toward normal osteoblastic hFOB 1.19 cells^[1].
IMPDH2-IN-4 inhibits recombinant IMPDH2 with a K_i,app of 1.8 μM, and does not inhibit IMPDH1^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Cytotoxicity Assay^[1]

Cell Line:

143B, MNNG/HOS, U2OS, SaOS-2, hFOB 1.19
Concentration:

0.1 μM, 1.0 μM, 10.0 μM, 100.0 μM for hFOB 1.19
Incubation Time:

72 h
Result:

Inhibited viability of 143B cells with an IC₅₀ of 1.65 μM.
Inhibited viability of MNNG/HOS cells with an IC₅₀ of 0.64 μM.
Inhibited viability of U2OS cells with an IC₅₀ of 1.01 μM.
Inhibited viability of SaOS-2 cells with an IC₅₀ of 2.27 μM.
Reduced hFOB 1.19 cell viability to 93.91% at 0.1 μM, 91.95% at 1.0 μM, 84.5% at 10.0 μM, and 73.34% at 100.0 μM.

Chemical Information

Masse moléculaire 578.73
Formule C₃₅H₃₄O₆Si
SMILES

O=C(O[Si](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3)CC/C(C)=C/CC4=C(O)C5=C(COC5=O)C(C)=C4OC
Livraison

Room temperature in continental US; may vary elsewhere.
Stockage

Please store the product under the recommended conditions in the Certificate of Analysis.

Pureté et documentation

Select Batch:

Pureté: 99.98%

Assay: 99.98%

ee.: 99.98%

Fiche technique (272 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Instruction de manipulation (2659 KB)

Références

[1]. Silalai P, et al. Design and Synthesis of Mycophenolic Acid Analogues for Osteosarcoma Cancer Treatment. ACS Bio Med Chem Au. 2024;5(1):106-118. Published 2024 Oct 17. [Content Brief]

Calculators

Calculateur de molarité

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

Calculateur de dilution

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Keywords

100 mg

Obtenir un devis En stock